Suggestions
Evan Bernier
Regional Vice President, Enterprise Sales
Evan Bernier is the Regional Vice President of Enterprise Sales at Omada Health, focusing on the Northeast region.12 He is an experienced Account Executive with a strong background in selecting appropriate staff members for companies, whether for temporary or permanent job placements.1
Professional Experience
At Omada Health, Evan plays a key role in the company's enterprise sales efforts. He frequently shares updates and insights about Omada Health's initiatives and achievements on his LinkedIn profile. Some of his recent posts highlight:
- Omada Health's journey with artificial intelligence2
- The company's clinical team's consistent efforts3
- Omada Health's proof points on primary care5
Industry Insights
Evan demonstrates a keen interest in various aspects of the healthcare and business landscape:
- He has shared research findings on the "Great Resignation" phenomenon4
- He discusses topics such as the potential replacement of primary care5
- He engages with content related to economic growth and industry trends7
Engagement and Networking
Evan is active on LinkedIn, regularly posting about:
- Industry conferences, such as #oncon20246
- Omada Health's initiatives and achievements
- Broader healthcare and business topics
His LinkedIn username is evanbernieradp, which is consistent across his profile and posts.123
Highlights
Have you heard about Omada Health's latest partnership? It’s an awesome success story of the Alaska Department of Health bringing Omada Health’s’s virtual care to residents across the state. As part of the Fresh Start Campaign, Omada is committed to addressing health equity and providing accessible care teams to those no matter their access to in-person care. Learn more: https://buff.ly/3YQsCRg
The Omada Health clinical team is consistently hard at work - and it shows!
Recently, Omada’s 29th peer-reviewed paper was published with the help of our partners Global Data in the AJMC - The American Journal of Managed Care. This study used a Markov model to estimate the reduction of disease onset and associated cost savings for our cardiometabolic programs. Want to see the figures?
Read the full study here: https://lnkd.in/eyXRpHVr
